Indian firm Zydus Lifesciences receives US FDA approval for generic dexamethasone tablets.

Indian pharmaceutical firm Zydus Lifesciences receives US FDA approval for generic dexamethasone tablets, used to treat arthritis, allergies, and cancer. This follows the approval for its Dapsone Gel for acne treatment. The tablets will be manufactured at the company's facility in Baddi, Himachal Pradesh. Zydus has 395 approvals and has filed over 460 Abbreviated New Drug Applications since its commencement in FY 2003-04.

May 11, 2024
3 Articles